3

PRIMARY DOCUMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: February 7, 2007
Period of Report: February 7, 2007
Accession Number: 0001078782-07-000090

View Document ↗ View on SEC.gov ↗